Axonify Receives Gold and Silver in Brandon Hall Group's 2024 Excellence in Technology Awards
Recognized with Gold Award for "Best Advance in Learning Management Measurement/Business Impact Tools," Silver Award for "Best Advance in a Generative AI Solution" WATERLOO, ON, Jan. 7, 2025 /PRNewswire/ -- Axonify, a global leader in frontline...
GSCF Acquires IBM Deutschland Kreditbank GmbH
Extends Connected Capital Ecosystem of Corporates and Bank Partners for Coverage Across the EU NEW YORK, Jan. 7, 2025 /PRNewswire/ -- GSCF, a leading global provider of working capital solutions, today announced the acquisition of IBM Deutschland...
Webull Canada Celebrates First Anniversary
TORONTO, Jan. 7, 2025 /PRNewswire/ -- Webull Canada, a subsidiary of Webull Corporation, the owner of the popular Webull digital investment platform, is proudly celebrating its first anniversary after a year of rapid growth, product innovation, and...
Avenzo Therapeutics and DualityBio Announce Exclusive Global License for Potential Best-In-Class EGFR/HER3 Antibody-Drug Conjugate
Avenzo to receive exclusive global license (excluding Greater China) for development, manufacturing and commercialization of potential best-in-class EGFR/HER3 antibody-drug conjugate EGFR and HER3 co-expressed across various solid tumors, including...
Beatbot Unveils the Revolutionary AI-Powered AquaSense 2 Ultra at CES 2025
Newly upgraded pool cleaning solutions and services elevate the industry standards and consumer experience to new heights. LAS VEGAS, Jan. 7, 2025 /PRNewswire/ -- Beatbot, the brand behind the world's most innovative robotic pool cleaners, has...
AiDot Offers Exclusive Foretaste of Cutting-Edge Smart Home Innovations at CES 2025
LAS VEGAS, Jan. 7, 2025 /PRNewswire/ -- AiDot, a leading innovator in smart home solutions, will showcase a preview of its latest advancements at CES 2025. Attendees will have the opportunity to experience firsthand the groundbreaking features of...
Insilico Received Positive Topline Results from Two Phase 1 Trials of ISM5411, New Drug Designed Using Generative AI for the Treatment of Inflammatory Bowel Disease
Two separate Phase I studies conducted in Australia and in China indicate that ISM5411 was generally safe and well tolerated in all dose groups, demonstrating a favorable PK profile in validating gut-restrictive properties. Supported by Insilico's...
Two New Products at CES: Hesai Showcases 1440-Channel Automotive Lidar and Next Gen Solid-State Lidar
Hesai (Nasdaq: HSAI) introduces new AT1440 with the world's highest number of channels for an automotive lidar and the FTX solid-state lidar with the world's widest field of view AT1440's resolution is more than 30 times higher than mainstream...